IRI participates in a new IMI (Innovative Medicines Initiative), AETIONOMY

IRI is the legal and ethical partner in an exciting new IMI (Innovative Medicines Initiative) project, AETIONOMY, which will analyse patient data to help uncover the causes of Alzheimer’s and Parkinson’s disease.

Further information about the project can be found in the official press release.

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind markiert *